#Clinical Trial Sourcing Services | Explore Tumblr posts and blogs

rakhisingh · 1 year ago

Text

An API developer in DigitalAPICraft Company thinks API will revolutionize the healthcare ecosystem

The rise of digital health solutions has transformed how we approach healthcare. APIs play a major role in this transformation, enabling seamless integration with existing systems and data sources. For instance, wearable devices and mobile health applications can utilize APIs to seamlessly transmit health data to EHRs, enabling healthcare providers to monitor patients remotely and gain valuable insights into their health status. API also enables the integration of telemedicine platforms, which allows patients to easily schedule medical appointments, securely share their medical information, and receive virtual care. APIs are sets of rules and protocols that allow different software applications to communicate and interact with each other. Here's how APIs could potentially revolutionize the healthcare ecosystem:

Innovation and Development: APIs can encourage innovation by allowing developers to create new applications and services that leverage healthcare data. For instance, wearable devices and health monitoring apps can connect to APIs to provide patients and healthcare providers with real-time health data.

Data Exchange and Integration: APIs can facilitate the secure exchange of patient data between healthcare providers, hospitals, clinics, and even patients themselves. This can lead to more coordinated and efficient care, as healthcare professionals can access the information they need in real-time.

Patient Empowerment: APIs can empower patients by giving them access to their own health data. Patients can use this data to make informed decisions about their health and share it with different healthcare providers as needed.

Research and Analytics: APIs can make it easier for researchers to access and analyze large sets of anonymized healthcare data for epidemiological studies, clinical trials, and medical research.

Security and Compliance: While APIs offer many benefits, data security and patient privacy are critical concerns in healthcare. Implementing robust security measures and complying with relevant regulations like HIPAA (Health Insurance Portability and Accountability Act) is essential when developing healthcare APIs.

Personalized Healthcare: APIs can enable the integration of patient data from various sources, which can then be used to provide personalized treatment plans and recommendations. This can lead to more effective treatments tailored to individual patients.

Telemedicine and Remote Monitoring: APIs can play a crucial role in telemedicine by enabling video consultations, remote patient monitoring, and virtual healthcare services. This is especially important in situations where in-person visits are challenging or not feasible.

Interoperability: APIs can enable different healthcare systems, such as electronic health records (EHR) platforms, medical devices, and mobile applications, to seamlessly exchange data and share information. This can lead to improved patient care by providing healthcare providers with a comprehensive view of a patient's medical history and data.

The API developer's belief in the revolutionary potential of APIs in the healthcare ecosystem is well-founded. However, it's important to recognize that while APIs offer tremendous opportunities, they also come with challenges that need to be carefully addressed to ensure the safe and effective use of healthcare data. One APIMarketplace comes with a package of features and benefits, which can totally change the way you run your organization and provide you with a much more efficient and hassle-free system, leading you to better results. So don’t wait visit DigitalAPICraft.com and get a free demo of One APIMarketplace today.

For more information: https://digitalapicraft.com/

#DigitalAPICraft #APIMarketplace

2 notes · View notes

trodelvy · 1 year ago

Text

Trodelvy Injection: A Game-Changer in Cancer Care

Trodelvy contains the active pharmaceutical ingredients sacituzumab govitecan. The medicine is used for the treatment of patients with triple-negative breast cancer (TNBC), HR+/HER2- metastatic breast cancer, and advanced bladder cancer. If you are searching for a genuine Trodelvy supplier from India, then Indian Pharma Network (IPN) can be your most reliable source/platform. IPN is WHO GDP & ISO 9001 2015 Certified Trodelvy Supplier, Wholesaler, Importer, and Exporter from India. Trodelvy which is Manufactured by Gilead Sciences, Inc, is available in a strength of 180 mg/mL. Trodelvy 180 mg is supplied for Tenders/ exports/ imports/ Named patient program/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples for Clinical trials. Indian Pharma Network is the legitimate source of Trodelvy (sacituzumab govitecan-hziy) for injection, all the customers can get in touch with us to buy/order/procure this pharmaceutical product in approved quantity.

Buy Trodelvy 180 mg Injection at Lowest Price from India

Trodelvy 180 mg for injection is designed to carry cancer-fighting drug to cells that have Trop-2 proteins. Certain tumor cells have high Trop-2 proteins. The medicine trodelvy 180 mg injection is approved for 3 different types of cancer:

Advanced Bladder Cancer

HR+/HER2- Metastatic Breast Cancer

Metastatic Triple Negative Breast cancer Trodelvy injection 180 mg is a type of antibody-drug conjugate (ADC) treatment that is designed to work differently than traditional chemotherapy. It is designed to deliver promising anticancer drug directly into cells with Trop-2 proteins.

Buy Trodelvy in India I Sacituzumab Govitecan 180 MG Vial

Trodelvy (sacituzumab govitecan) is a type of medicinal product known as antibody-drug conjugate, or ADC for short. Unlike typical (traditional) chemotherapy, ADCs consist of three parts: an antibody, an anticancer medicine, and a linker. If you want to buy trodelvy in India for triple-negative breast cancer, HR+/HER2- metastatic breast cancer, and advanced bladder cancer, then Indian Pharma Network (IPN) can be your one-stop solution.

We are famed and esteemed in the pharmaceutical industry for our best quality service, vast industry experience, market credentials, and timely delivery. Our all the tie-ups and sourcing from the reputed brands allow us to offer the best price for Trodelvy 180 mg vial. Trodelvy (sacituzumab govitecan 180 mg vial) is an intravenous (IV) infusion (10mg/kg). Proposed doses are administered once weekly for two weeks (Day 1 and 8) of 21-day treatment cycles. Each treatment cycle is 21 days (3 weeks).

Sacituzumab Govitecan- Trodelvy Price for 180 MG Vial in India

Trodelvy is made of two different drugs joined together: a monoclonal antibody drug (which attaches to Trop -2 receptors, present on the outside of some cancer cells, and a chemotherapy drug (which stops all cells including unhealthy cells from growing and dividing). The monoclonal antibody drug attaches to the unhealthy cells and then releases the chemotherapy medicine directly into the cell. All pharmaceutical products – comparator drugs, adjunctive therapies, RLDs, co-meds and rescue meds, and Exports/Imports drugs – are transported in standard temperature-controlled conditions with active monitoring in order to ensure the integrity of products. Contact us today to get/buy your hard-to-access prescription medicine at the lowest price from India.

#trodelvy in India #trodelvy price in India #trodelvy suppliers in noida #importers of trodelvy from india #innovator drug suppliers

2 notes · View notes

drtylerbuckley · 2 years ago

Text

Do Cancer Clinical Trials Work?

You could be invited to think about participating in a clinical study if you or a loved one is given a cancer diagnosis. These studies examine brand-new medications and other medical procedures that might enhance your care. These studies contribute significantly to our knowledge of cancer and advanced methods for its detection, diagnosis, treatment, and care. They also advance our understanding of how cancer develops and identify effective methods against certain tumors.

Phase I studies are physicians' initial examinations of novel cancer treatments. The medicine is tested to determine the best way to administer it and whether it is safe for humans. In these trials, a limited number of patients get the medication in escalating dosages. Doctors closely monitor each patient's side effects to determine the appropriate dosage.

To determine the safety of the treatment, scientists also test it on cancer cells in a test tube or lab dish, as well as on animals. Phase II studies for the medication begin if these tests show promise. These studies give people with a specific kind of cancer a new medication. It is a response if cancer temporarily stops growing or shrinks.

In clinical trials, new medications are tested on a limited number of cancer patients (called a "cohort"). They also research the drug's effectiveness and potential adverse effects. After Phase I testing, a medicine undergoes Phase II trials, which typically concentrate on a specific form of cancer. The goal is to determine if the medication shortens lifespans or reduces tumor size.

These studies, also known as "cohorts," typically include 15 to 50 participants. To determine how the medications affect these individuals, doctors collect blood and urine samples from them. In the early days of cancer medication research, phase II studies were virtually invariably nonrandomized, and nearly all employed tumor response as their primary outcome. However, this method is now unacceptable due to the development of molecularly targeted treatments.

A crucial step in the cancer research process is clinical trials. They enable us to understand the operation of novel medications, radiation treatment, surgical techniques, and their safety and efficacy. The number of patients ranges from hundreds to thousands. The innovative treatment or the conventional treatment is randomly allocated to each patient.

Researchers often examine if a novel treatment results in a higher quality of life, a longer life expectancy, and fewer adverse effects than the current standard of care. Additionally, they check to determine if the novel therapy stops cancer from returning more frequently than the conventional therapy. If the novel therapy is successful, researchers could proceed to Phase III investigations. Because fewer individuals are in these trials and more medications are used, they are more rigorous than phase II research.

Multi-institutional studies, called cooperative group trials, examine innovative cancer diagnosis, screening, prevention, and care delivery methods. A nationwide network of academic researchers, cancer treatment facilities, and general practitioners carry out these studies.

The National Cancer Institute (NCI) has financed cooperative group trials since the 1950s. By creating efficient combination regimens, these early group studies intended to raise the cure rate for leukemia and other malignancies.

With growing support from outside sources, the cooperative groups gradually broadened their focus to encompass studies including cancer screening and prevention, biomarker discovery and validation, and health services research. This expanded the scope of cooperative group research to fulfill the needs of a fast-evolving environment in the field of cancer science.

These adjustments have been beneficial, although the NCI continues to encounter obstacles. Due to this, the NCI recently reorganized and changed the name of its cooperative group program to the National Clinical Trials Network. As a result, research-creation times have been shortened, and NCTN members now have access to standardized remote data-collecting systems, yet numerous problems persist.

2 notes · View notes

clinicalmanuscript · 1 day ago

Text

A Guide To Effective Manuscript Writing For Science Journals

Creating a compelling manuscript for high-impact science journals like those indexed in Scopus and PubMed requires a careful blend of clarity, structure, and attention to detail. ClinicalManuscript.com offers valuable guidance to help you meet these standards and improve your chances of publication. Here’s a comprehensive guide with essential tips for writing an effective manuscript for science journals.

— -

### Focus on Clear, Simple Language

Clear language is essential in scientific writing. Use simple, straightforward words to express complex ideas without confusing your readers. Avoid jargon and elaborate sentences, opting instead for concise explanations that make your research accessible to a broad audience. Science journals value clarity and brevity, as these traits make your findings more accessible to experts and non-experts alike. ClinicalManuscript.com offers resources that can help you refine your language, ensuring your research reaches a wider readership.

### Follow a Structured, Logical Format

A logical structure is essential for a science manuscript, often following the IMRAD (Introduction, Methods, Results, and Discussion) format. This format allows readers to understand the purpose, approach, findings, and implications of your study in a clear and organized manner. Each section should have a specific purpose and flow naturally into the next, providing a coherent and compelling narrative. ClinicalManuscript.com can assist you in organizing your manuscript effectively, helping you create a document that is both professional and easy to navigate.

### Highlight Main Findings Early On

Start by introducing your main findings upfront, especially in the abstract and conclusion sections. Many readers skim through abstracts, so placing your key discoveries early can capture their attention and give them a reason to continue reading. This approach helps both reviewers and readers understand the significance of your work at a glance, increasing the likelihood of a positive response from journal editors and reviewers. ClinicalManuscript.com’s guidelines emphasize this approach, making your research stand out in a competitive field.

### Keep Language Precise and Concise

Precision and conciseness are paramount in scientific writing. Avoid unnecessary words and elaborate descriptions that could dilute your main points. Instead, aim to communicate each idea as clearly and directly as possible. Precision in language also improves readability, making it easier for readers to follow your argument without distraction. ClinicalManuscript.com provides editing tools and resources to help you achieve the clarity and brevity that high-impact journals seek.

### Ensure Smooth, Coherent Flow Throughout

Each section of your manuscript should transition smoothly to the next, creating a coherent narrative. This flow helps readers follow your reasoning and understand how each part of your study contributes to the overall findings. Use transition phrases and logical connections to guide readers through complex ideas and analyses. A coherent manuscript is not only more readable but also reflects well on your professionalism and attention to detail. ClinicalManuscript.com’s editing services can help you create a polished and well-organized document.

### Back Claims with Strong Evidence

Scientific manuscripts rely heavily on evidence-based claims. Support your conclusions with data from reputable studies, clinical trials, or systematic reviews to demonstrate the credibility of your findings. Journals indexed in Scopus and PubMed prioritize research that is well-supported by evidence, as it enhances the reliability and impact of the publication. ClinicalManuscript.com offers resources to help you find and incorporate relevant, credible sources, ensuring your manuscript meets the rigorous standards of these journals.

### Align Content with Journal Guidelines

Each journal has unique requirements regarding formatting, structure, and content style. Familiarize yourself with the specific guidelines of the journal to which you’re submitting your manuscript. Adherence to these requirements not only increases your chances of acceptance but also demonstrates professionalism and respect for the publication’s standards. ClinicalManuscript.com provides tools and templates tailored to the guidelines of various high-impact journals, making it easier for you to align your manuscript with these standards.

### Proofread Meticulously to Catch Errors

Errors in spelling, grammar, or formatting can distract reviewers and undermine your manuscript’s credibility. Proofread thoroughly to catch and correct any mistakes. A polished, error-free manuscript is more likely to make a good impression on journal editors and reviewers. ClinicalManuscript.com offers proofreading services that can help identify and correct any issues in your manuscript, ensuring it is clean, professional, and ready for submission.

/media/9debf8f4de1fee79e48aa4e9f0373484

— -

### FAQs

**Q1: Why is simple language important in scientific writing?**

Simple language makes scientific findings more accessible, allowing a broader audience to understand complex research without unnecessary jargon or complicated phrasing. Science journals prioritize clarity, as it enables readers across various fields to comprehend and appreciate the research. By using straightforward language, authors can communicate their findings effectively, improving the likelihood of a positive response from reviewers and readers. ClinicalManuscript.com helps researchers refine their language, ensuring it aligns with the clarity standards expected by high-impact journals.

**Q2: What is the IMRAD structure, and why is it effective?**

The IMRAD structure — Introduction, Methods, Results, and Discussion — is a widely accepted format in scientific writing. It organizes research in a logical flow, guiding readers from the background to the methodology, findings, and implications of the study. This structure is effective because it breaks down complex research into manageable sections, making it easier for readers to follow the study’s progression. ClinicalManuscript.com offers guidance on implementing the IMRAD structure, ensuring a professional and organized manuscript that meets journal expectations.

**Q3: How does highlighting main findings early benefit my manuscript?**

Presenting main findings early, especially in the abstract, captures the reader’s attention and provides a clear understanding of your study’s significance. Many reviewers and readers skim through the abstract, so highlighting the key discoveries right away makes your work more engaging and accessible. Early emphasis on findings also shows the relevance of your research, encouraging readers to delve deeper into the study. ClinicalManuscript.com’s guidelines emphasize this approach, helping authors create compelling and impactful manuscripts.

**Q4: Why is backing claims with evidence essential in scientific writing?**

Evidence-based claims lend credibility to a manuscript, demonstrating that conclusions are supported by reliable data. This practice reassures readers and reviewers that the findings are trustworthy and that the study adds valuable insight to the field. High-impact journals like those in Scopus and PubMed require manuscripts to be evidence-driven, as this aligns with scientific rigor. ClinicalManuscript.com provides resources to help authors locate credible sources and build a strong evidence base for their research.

**Q5: How can proofreading improve my chances of publication?**

Proofreading eliminates errors that can detract from a manuscript’s professionalism and clarity. Grammar mistakes, typos, and formatting inconsistencies can distract reviewers and reflect poorly on the author’s attention to detail. A thoroughly proofread manuscript appears polished, increasing its chances of acceptance by science journals. ClinicalManuscript.com offers proofreading services to help authors present error-free, high-quality work that meets the standards of leading journals, improving the likelihood of a successful submission.

— -

### Conclusion

Writing an effective manuscript for science journals requires a strategic and meticulous approach. By focusing on clear language, following a logical structure, highlighting findings early, using precise language, ensuring coherence, backing claims with evidence, aligning with journal guidelines, and proofreading carefully, you can improve your manuscript’s quality and impact. ClinicalManuscript.com provides comprehensive support, guiding you through each stage of manuscript preparation to help you achieve your publication goals in Scopus and PubMed journals. Start your journey with ClinicalManuscript.com today and make your research stand out in the scientific community.

### Stay Connected with Clinical Manuscript Youtube Channel!

Stay connected with the Clinical Manuscript YouTube Channel for expert guidance on preparing and publishing high-quality research. Our channel offers valuable insights and step-by-step tutorials to help you develop, polish, and submit manuscripts for top international journals, including those indexed in Scopus and PubMed. Whether you’re aiming to enhance your writing, understand journal selection, or navigate submission requirements, Clinical Manuscript provides the tools you need to succeed in reaching Q1 journal standards. Subscribe now to unlock resources that make the publishing journey smoother and more successful, ensuring your research gains the visibility and impact it deserves.

### Stay Connected with Clinical Manuscript Youtube Channel!

#manuscript

0 notes

elaphh · 6 days ago

Text

Unlocking global opportunities with precise technical translations in Dubai

Communication becomes very vital as the business expands its horizons in a fast-evolving global market. No one place may be more illustrative than this cosmopolitan oasis, city of interfaith and international trade, tourism, and innovation, that lies in Dubai. Technical translations to cut across geography have dramatically increased as businesses reach the farthest limits to emerge beyond territorial and linguistic boundaries. Now, it is possible for any organization to reach out to this kind of varied global prospect through professional technical translation services, which can be found in Dubai with good technical translators.

Role of Technical Translation:

Technical translation from a source language into another maintains the original intent, terminology, and context with utmost care. Technical translation is indispensable for industries like engineering and information technology, where certain terminologies may often be very complicated, almost impossible, and highly regulated. For example, any medical translation service in Dubai must strictly adhere to guidelines to yield accuracy and compliance with regional and international regulations.

Why Dubai?

Dubai is at the crossroads between Europe, Asia, and Africa, and this positioning makes it an excellent location for multinational corporations and professionals looking to interact across borders. The city is a cosmopolitan "mélange" of cultures with more than 200 nationalities residing within its boundaries. This diversity only amplifies the need for professional translation services, as businesses need to serve customers and partners who speak several languages. Accurate translations are not only the practices of effective communication from a company's aspect but also promise trust from stakeholders.

Importance of Precision

For technical documents, precision is the key. In operational failures, legal complications, and even safety hazards, mistranslated terms or even ambiguous phrases may lead to a catastrophe. For instance, in pharmaceutical and other relevant fields, the drug manuals could be translated with a slight alteration, which is pretty fatal for health. Thus, dealing with an experienced technical translation services company in Dubai will allow your documents to reach experts who are more than just linguists but go an extra mile to know specific technical fields. With expertise in their delivery of translations that fit standards in their industries, such risks can be minimized and efficiency in operation increased.

Multi-Functional Services

A professional translation services company in Dubai provides a range of services, each meeting distinct requirements and types of documents, for different sectors. For businesses in the medical field, employing medical translation services in Dubai is of paramount importance. These services usually include patient records, clinical trials, research, and marketing. As such, the medical jargon translators have means crucial information is communicated without any failure to either the organization or its patients.

Other industries involved in engineering, finance, and technology likewise rely on proper translation services. These include technical guides, localization of software applications, preparation of financial statements, and development of marketing literature in the type of service that a translation office Dubai can offer, customized to specific business requirements.

Cultural Translation Requirements

Translation is not only text conversion, but also the understanding of cultural nuances. A good translator needs to understand the culture, expectations, and sentiments of the target audience. In a cosmopolitan city like Dubai, one needs to be sensitive to all this. Whether the company is introducing a new product or extending its service offerings, culturally relevant translations can make all the difference in marketing efforts as well as customer engagement.

Making Decisions

In finding a technical translation service provider in Dubai, companies would need to pick companies with a good history and record. Such factors may include years of experience in the specific or any industry, clients' testimonials, and also the versatility in translation professionals employed by the firm. A high-quality translation services investment is not just a cost but a strategic sound decision likely to spur sales, improve brand reputation, and establish a firm footing into the international market.

The globalized economy and accurate technical translations are no longer choices, but are a necessity for many companies. In this regard, partnering with a company offering professional translation services Dubai works wonders by allowing business firms to communicate their ideas and products across diverse markets. The scope for expansion into global levels is immense-from medical translation services Dubai to all-inclusive technical solutions. This fast-paced city shall thus open the door to the opportunities by translating it accurately in a culturally correct way. Navigating these complexities, with the right partnering agencies, can lead organizations to outstanding success in international business.

#arabic legal translation services #certified legal translation in dubai #interpretation services in dubai #website localization service in dubai #professional translation services dubai #arabic translation service dubai

0 notes

ristesh · 21 days ago

Text

The Future of Conversational AI Analytics in Life Sciences Business

What is Conversational AI Analytics?

Conversational AI analytics refers to the use of artificial intelligence and natural language processing to analyze conversations between humans and machines. In the life sciences industry, this technology can be applied to a wide range of applications, from patient support to drug discovery.

Key Applications of Conversational AI Analytics in Life Sciences

Patient Support and Engagement

Personalized Support: Conversational AI in Life Sciences can provide personalized support to patients, answering their questions and addressing their concerns.

Improved Adherence: AI-powered chatbots can help patients adhere to their treatment plans by providing reminders and offering support.

Early Detection: By analyzing patient conversations, AI can identify early signs of adverse events or changes in health status.

Medical Research and Data Analytics

Data Extraction: Conversational AI can be used to extract valuable insights from unstructured data, such as medical records and clinical trial data.

Knowledge Management: AI-powered chatbots can serve as knowledge bases, providing access to medical information and research findings.

Drug Discovery: Conversational AI can be used to accelerate drug discovery by analyzing vast amounts of biomedical data and identifying potential drug targets.

Clinical Trial Optimization

Patient Recruitment: AI-powered chatbots can help recruit patients for clinical trials by identifying potential participants and engaging them in the process.

Data Collection: Conversational AI can be used to collect patient data more efficiently and accurately, improving the quality of clinical trials.

Remote Monitoring: AI-powered chatbots can monitor patients remotely, reducing the burden on healthcare providers and improving patient outcomes.

What’s Next for Conversational AI Analytics in Life Sciences?

Real-Time Data and Predictive Analytics

Real-Time Insights: Conversational AI can be used to analyze real-time data from various sources, such as wearable devices and electronic health records.

Predictive Analytics: AI can be used to predict future trends and outcomes, such as disease progression or treatment effectiveness.

Personalized Patient Experiences

Tailored Recommendations: Conversational AI can be used to provide personalized recommendations for treatments, lifestyle changes, and self-care.

Virtual Care: AI-powered chatbots can provide virtual care services, such as remote consultations and medication management.

Conversational AI for Global Healthcare Access

Language Barriers: Conversational AI can be used to overcome language barriers and provide healthcare services to people in remote or underserved areas.

Accessibility: AI-powered chatbots can make healthcare services more accessible to people with disabilities or limited mobility.

Conclusion

Conversational AI analytics has the potential to revolutionize the life sciences industry by improving patient outcomes, accelerating drug discovery, and enhancing healthcare access. As AI technology continues to advance, we can expect to see even more innovative applications of conversational AI in the years to come.

0 notes

industrynewsupdates · 28 days ago

Text

Clinical Trials Market Share, Growth Analysis Top Leading Players 2024 - 2030

The global clinical trials market size is expected to reach USD 123.5 billion by 2030, expanding at a CAGR of 6.49% from 2024 to 2030, according to a new report by Grand View Research, Inc. An increase in the volume and complexity of clinical trials has been witnessed lately, which plays an important role in the R&D of new drugs and products. The market witnessed a decline of 6% in 2020 owing to the COVID-19 pandemic. However, the market is projected to recover from 2021 onwards. In addition, clinical trials have become increasingly costly, adding to the overall cost of developing a drug.

The increasing need for developing new drugs for chronic diseases, such as cancer, respiratory disorders, diabetes, cardiovascular diseases, and others, is creating immense pressure on the healthcare industry. The COVID-19 pandemic and the increasing demand for developing a suitable treatment are driving the market. The high number of people affected by the disease further depicts an increasing need for therapeutics & vaccines. Currently, there are 288 therapeutics and 106 vaccines under development, out of which, nearly 7.0% of therapeutics are in Phase IV, 21.0% in Phase III, and 43.0% & 13.0% in Phase II & Phase I, respectively.

Gather more insights about the market drivers, restrains and growth of the Clinical Trials Market

Detailed Segmentation:

Market Concentration & Characteristics

The industry growth stage is moderate, and the pace of the growth is accelerating. The clinical trials market is characterized by a moderate-to-high degree of growth owing to increasing investment in R&D programs, growing preference for outsourcing activities to minimize time, curtail clinical trial cost and patent expiration of blockbuster drugs. With increasing clinical trial privatization, there is a surge in outsourcing to developing countries, and many CROs are enhancing their global research network to provide better customer services.

Phase Insights

Phase III segment led the market and accounted for 53.3% of the total revenue share in 2023. clinical trial statistics indicate market growth due to rising phase III trials, involving a large number of subjects. The median cost for a single-phase III trial is over USD 19.0 million. Also, phase III requires a higher number of patients and often a longer treatment period. According to a clinical trial logistics survey by Nice Insights, 35.0% of phase III clinical trials are outsourced and the number is likely to increase owing to the growing number of investigational drugs advancing to the next phase.

Study Design Insights

The interventional studies segment dominated the market in 2023. It is one of the most prominent methods used in clinical trials. Interventional studies comprised over 75.0% of the total registered studies in 2022,ut of which most were for drug or biologics, followed by clinical procedure, behavioral, and device interventional studies. These studies contribute to 94.0% of the total studies that posted results, out of which drug or biologics contribute the most, followed by behavioral, devices, and Clinical procedure intervention studies.

Indication by Study Design Insights

The interventional trials market for autoimmune/inflammation accounted for the largest revenue share in 2023. This can be attributed to large number of interventional studies on autoimmune/inflammation worldwide. Numerous advantages of interventional studies, such as minimization of confounding effects, avoidance of bias in allocation to exposure groups, and efficient detection of small to moderate clinically important effects. There are over 8,900 interventional studies listed on Clinicaltrails.gov related to autoimmune/inflammation.

Indication Insights

Oncology segment accounted for the largest revenue share in 2023. As per the U.S. FDA and various other sources, more than USD 38.0 billion is currently being spent by the pharmaceutical industry on the pre-clinical and clinical development of oncology therapy products. The cardiovascular condition segment is also anticipated to witness lucrative growth over the forecast period. The growing prevalence and increased demand for cost-effective medications worldwide have led to significant investment in R&D in this segment with more than 190 drugs in the pipeline. The majority of the drugs in the pipeline are indicated for heart failure, lipid disorders, vascular diseases, and stroke. Growing demand for cost-effective medicines in low- and middle-income countries is expected to boost the R&D investment by the government, thereby strengthening the industry growth.

Sponsors Insights

Pharmaceutical & biopharmaceutical companies accounted for the largest revenue share in 2023. This can be attributed to the greater interest of the pharmaceutical industry in the research field. In addition, there has been an increase in the number of clinical trials funded by pharmaceutical & biopharmaceutical companies. The pharmaceutical industry plays a vital role in financing the research for the development of new drugs.

Regional Insights

North America accounted for 50.3% of the global market in 2023 and is expected to continue its dominance over the forecast period. This can be attributed to an increase in R&D investments and a rise in the adoption of new technologies in clinical trials in this region. For instance, the implementation of virtual services in various stages of clinical trials by market players, such as IQVIA and PRA Health Sciences, is anticipated to further propel the North American market growth.

Browse through Grand View Research's Healthcare IT Industry Research Reports.

• The global healthcare predictive analytics market size was estimated at USD 14.58 billion in 2023 and is projected to grow at a CAGR of 24.0% from 2024 to 2030.

• The global medical animation market size was valued at USD 396.2 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 20.1% from 2024 to 2030.

Key Companies & Market Share Insights

The global clinical trials market is highly competitive. Some of the players operating in the market include IQVIA, PAREXEL International Corporation, Pharmaceutical Product Development, LLC, and Charles River Laboratory. The major factor influencing the competitive nature is the quick adoption of advanced technology for improved healthcare. In addition, to retain their market share and expand their product portfolio, major players are often involved in mergers and acquisitions as well as initiating new product launches.

Key Clinical Trials Companies:

• Pharmaceutical Product Development, INC. (Thermo Fisher Scientific, Inc.)

• ICON plc

• Charles River Laboratories International, Inc.

• IQVIA

• SYNEOS HEALTH

• SGS SA

• PAREXEL International Corporation

• Wuxi AppTec, Inc

• Chiltern International Ltd (Laboratory Corporation of America)

• Eli Lilly and Company

• Novo Nordisk A/S

• Pfizer

• Clinipace (Caidya)

Clinical Trials Market Segmentation

Grand View Research has segmented the global clinical trials market based on phase, study design, indication, sponsor, indication by study design, and region:

Clinical Trials Phase Outlook (Revenue, USD Billion, 2018 - 2030)

• Phase I

• Phase II

• Phase III

• Phase IV

Clinical Trials Study Design Outlook (Revenue, USD Billion, 2018 - 2030)

• Interventional

• Observational

• Expanded Access

Clinical Trials Indication by Study Design Outlook (Revenue, USD Billion, 2018 - 2030)

• Autoimmune/Inflammation

o Rheumatoid Arthritis

o Multiple Sclerosis

o Osteoarthritis

o Irritable Bowel Syndrome (IBS)

o Others

• Pain Management

o Chronic Pain

o Acute Pain

• Oncology

o Blood Cancer

o Solid Tumors

o Other

• CNS Condition

o Epilepsy

o Parkinson's Disease (PD)

o Huntington's Disease

o Stroke

o Traumatic Brain Injury (TBI)

o Amyotrophic Lateral Sclerosis (ALS)

o Muscle Regeneration

o Others

• Diabetes

• Obesity

• Cardiovascular

• Others

Clinical Trials Indication Outlook (Revenue, USD Billion, 2018 - 2030)

• Autoimmune/Inflammation

o Interventional

o Observational

o Expanded Access

• Pain Management

o Interventional

o Observational

o Expanded Access

• Oncology

o Interventional

o Observational

o Expanded Access

• CNS Condition

o Interventional

o Observational

o Expanded Access

• Diabetes

o Interventional

o Observational

o Expanded Access

• Obesity

o Interventional

o Observational

o Expanded Access

• Cardiovascular

o Interventional

o Observational

o Expanded Access

• Others

o Interventional

o Observational

o Expanded Access

Clinical Trials Sponsor Outlook (Revenue, USD Billion, 2018 - 2030)

• Pharmaceutical & Biopharmaceutical Companies

• Medical Device Companies

• Others

Clinical Trials Service Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Protocol Designing

• Site Identification

• Patient Recruitment

• Laboratory Services

• Bioanalytical Testing Services

• Clinical Trial Data Management Services

• Others

Clinical Trials Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o U.K.

o Germany

o France

o Spain

o Italy

• Asia Pacific

o India

o Japan

o China

o Australia

o South Korea

• Latin America

o Brazil

o Mexico

o Argentina

o Colombia

• Middle East & Africa

o South Africa

o Saudi Arabia

o UAE

Order a free sample PDF of the Clinical Trials Market Intelligence Study, published by Grand View Research.

Recent Developments

• In August 2023, Parexel & Partex entered a strategic partnership aimed at utilizing Artificial Intelligence (AI)-driven solutions to expedite the process of drug discovery and development for biopharmaceutical clients globally. The collaboration aimed to reduce risks associated with the assets in their respective portfolios.

• In August 2023, Novo Nordisk announced to acquire Inversago Pharma. This acquisition was part of Novo Nordisk's strategic efforts to develop new therapies targeting individuals with obesity, diabetes, and other significant metabolic diseases

• In April 2022, Charles River Laboratories International, Inc. disclosed its acquisition of Explora BioLabs Holdings, Inc., a leading provider of contract vivarium research services.

#Clinical Trials Market #Clinical Trials Market size #Clinical Trials Market share #Clinical Trials Market analysis #Clinical Trials Industry

0 notes

vitti-labs · 29 days ago

Text

Unlocking Medical Breakthroughs with Vitti Labs, an FDA Registered Tissue Bank

At Vitti Labs, a leading FDA-registered tissue bank, we are advancing life science research, development, and manufacturing. We offer a wide range of bioethically sourced human tissue products (HCT/Ps), ensuring the highest quality and compliance. In addition to our tissue bank services, we actively engage in innovative clinical trials, tackling critical areas such as stem cells, infertility, autism, and more. With a commitment to advancing medical breakthroughs, we invite you to explore our research initiatives and partner with us to shape the future of healthcare. Contact us today to be part of this exciting journey.

#Tissue bank #research

0 notes

ikrispharmaa · 6 months ago

Text

#Clinical trial sourcing #clinical trial supplies #Reference listed drug supplier #rld service and suppliers #comparator sourcing for clinical trials #Brazil RLD Suppliers #Poland RLD Suppliers #Biologic reference products #Best Reference listed drug supplier

1 note · View note

foodresearchlab · 1 month ago

Text

Herbal - Ayurvedic-Guires Foodresearchlab

The global demand for natural and holistic health solutions is on the rise, with herbal and Ayurvedic products gaining significant traction. These traditional systems of medicine, rooted in natural ingredients and ancient wisdom, offer a holistic approach to health and wellness. As consumers become increasingly aware of the benefits of natural products, the market for herbal and Ayurvedic solutions continues to expand. This blog delves into the importance of herbal products services and herbal contract manufacturing services in meeting this growing demand and ensuring the delivery of high-quality, effective products.

The Growing Popularity of Herbal and Ayurvedic Products

Herbal and Ayurvedic products have been used for centuries to treat a variety of ailments, promote general wellness, and maintain a balanced lifestyle. Ayurveda, a traditional Indian system of medicine, emphasizes the balance of body, mind, and spirit, using natural ingredients such as herbs, minerals, and oils. This holistic approach has gained popularity in the modern era as consumers seek alternatives to synthetic drugs and chemicals.

The global herbal market is projected to reach USD 230 billion by 2028, driven by increasing consumer preference for natural products, rising health consciousness, and growing awareness of the side effects associated with synthetic drugs. This surge in demand has created opportunities for businesses involved in the production and distribution of herbal and Ayurvedic products.

The Need for Specialized Herbal Products Services

Creating effective herbal and Ayurvedic products requires specialized knowledge and expertise. Herbal products services encompass a wide range of offerings, including research and development, formulation, sourcing of raw materials, and quality control. These services are essential for ensuring that products meet the highest standards of safety, efficacy, and quality.

1. Research and Development (R&D):

R&D is the cornerstone of any successful herbal product. It involves the exploration of various herbs and natural ingredients, understanding their properties, and determining the optimal formulations for specific health needs. Advanced R&D services can also include clinical trials to validate the efficacy of products and ensure they meet regulatory standards.

2. Formulation:

The formulation of herbal products is a complex process that requires a deep understanding of the interactions between different herbs and ingredients. Expert formulation services ensure that the products are not only effective but also safe for consumption. This includes creating balanced formulas that enhance the therapeutic properties of the ingredients while minimizing potential side effects.

3. Sourcing and Procurement:

The quality of herbal products depends largely on the quality of the raw materials used. Sourcing and procurement services play a critical role in ensuring that herbs and other natural ingredients are obtained from reliable, sustainable sources. This involves working with trusted suppliers, verifying the authenticity of raw materials, and ensuring they are free from contaminants.

4. Quality Control:

Rigorous quality control measures are essential to ensure the safety and efficacy of herbal products. This includes testing for purity, potency, and consistency, as well as compliance with regulatory standards. Quality control services help maintain the integrity of herbal products and build consumer trust.

The Importance of Herbal Contract Manufacturing Services

With the increasing demand for herbal and Ayurvedic products, many businesses are turning to herbal contract manufacturing services to meet their production needs. These services offer several benefits, including cost savings, scalability, and access to specialized expertise.

1. Cost Savings:

Setting up an in-house manufacturing facility for herbal products can be a costly endeavor. Herbal contract manufacturing services allow businesses to save on capital expenditure, as they do not need to invest in expensive equipment, facilities, or skilled labor. Instead, they can leverage the resources and expertise of a contract manufacturer to produce their products.

2. Scalability:

As demand for herbal products grows, businesses need the ability to scale their production quickly and efficiently. Contract manufacturing services provide the flexibility to ramp up production volumes without the need for significant investments in infrastructure. This allows businesses to respond to market demand and seize growth opportunities.

3. Access to Expertise:

Herbal contract manufacturing services offer access to specialized knowledge and expertise in the production of herbal and Ayurvedic products. These manufacturers are well-versed in the complexities of herbal formulations, quality control, and regulatory compliance. By partnering with a contract manufacturer, businesses can ensure that their products meet the highest standards of quality and efficacy.

4. Regulatory Compliance:

The herbal and Ayurvedic product industry is subject to stringent regulatory requirements. Herbal contract manufacturers are equipped with the necessary knowledge and experience to navigate the complex regulatory landscape. They ensure that products comply with local and international regulations, including labeling requirements, safety standards, and quality certifications.

The Future of Herbal and Ayurvedic Products

The future of herbal and Ayurvedic products looks promising, with continued growth expected in the coming years. As consumers increasingly prioritize natural and holistic health solutions, the demand for high-quality herbal products will continue to rise. Businesses that invest in herbal products services and herbal contract manufacturing services will be well-positioned to capitalize on this trend and deliver products that meet consumer expectations.

In addition to the traditional market for herbal and Ayurvedic products, new opportunities are emerging in areas such as personalized medicine, wellness tourism, and functional foods. These trends are driving innovation in the herbal product space, with companies exploring new formulations, delivery methods, and applications for natural ingredients.

Conclusion

Herbal and Ayurvedic products are at the forefront of the natural health and wellness movement. With the growing demand for these products, businesses must ensure that they are offering high-quality, effective solutions that meet consumer needs. Herbal products services and herbal contract manufacturing services play a crucial role in this process, providing the expertise, resources, and scalability needed to succeed in the competitive herbal product market. By partnering with trusted service providers, businesses can unlock new opportunities and contribute to the ongoing growth of the herbal and Ayurvedic industry.

guiresfoodresearchlab

#Ayurvedic R&D

0 notes

sudheervanguri · 1 month ago

Text

Cognitive, a leading IT services firm based in Chennai, is currently hiring freshers for the role of Clinical Data Management Associate. This is an excellent opportunity for graduates with a background in Life Sciences, Biotechnology, or related fields to kickstart their career in one of the fastest-growing sectors in the healthcare industry. If you are passionate about healthcare, enjoy working with data, and have a keen eye for detail, this role is for you! About Cognitive: Innovating with Technology and Data Cognitive is a well-established IT services firm, headquartered in Chennai, India. With its focus on providing cutting-edge technology solutions across various industries, Cognitive has made a name for itself in offering reliable and innovative solutions. The company is known for its expertise in government, manufacturing, and retail sectors, but it is also expanding its footprint in healthcare and clinical research services. Job Role: Clinical Data Management Associate Location: Chennai, India Position Type: Full-time Joining Date: Immediate to 15 days As a Clinical Data Management Associate, you will be responsible for managing clinical trial data to ensure data accuracy, consistency, and completeness. You will play a pivotal role in supporting clinical research efforts by organizing and maintaining clinical databases, which are critical for drug development processes. Key Responsibilities: Assist in setting up, testing, and maintaining clinical trial databases. Ensure data integrity and accuracy by verifying data against source documents. Perform data entry, validation, and query management using clinical trial software. Collaborate with cross-functional teams including Clinical Operations, Biostatistics, and Data Management to ensure smooth data flow and reporting. Assist in generating and reviewing reports for data analysis and quality checks. Follow Standard Operating Procedures (SOPs) and Good Clinical Practice (GCP) guidelines to ensure regulatory compliance. Provide support for data audits and reviews. Qualifications and Skills Required Minimum Qualifications: Bachelor’s degree in Life Sciences, Biotechnology, Pharmacy, or a related field. Freshers are welcome to apply; candidates with up to 6 months of experience in clinical data management or related fields will have an advantage. Proficiency in MS Office, especially Excel, is required. Knowledge of clinical trial software or database management systems will be a plus. [caption id="attachment_106336" align="aligncenter" width="640"] Fresher Clinical Data Management Hiring Cognitive Chennai[/caption] Key Skills: Attention to detail and problem-solving skills. Strong organizational and time management abilities. Good communication skills and the ability to work in a collaborative environment. Ability to handle multiple tasks efficiently in a fast-paced setting. How to Apply If you are enthusiastic about clinical data management and meet the qualifications outlined above, we encourage you to apply now! Send your resume to [email protected] Deadline to Apply: October 14, 2024 (only a few days left!)

0 notes

govindhtech · 2 months ago

Text

Samsung Health Research Stack 2.0 Beta Version By Samsung

Samsung Health Research Stack

Precise data measurement and analysis are becoming more and more crucial as the wearables and digital health sectors expand. To support data-driven digital health research, Samsung Electronics unveiled Samsung Health Research Stack.

The open-source Samsung Health Research Stack project from Samsung Electronics facilitates digital health research employing wearables and mobile devices in Wear OS and Android environments. The platform offers a software environment for medical researchers and IT developers to easily and securely arrange services utilizing pertinent data.

Samsung Health Research Stack attempts to assist researchers in putting their desired features into practice because clinical research necessitates apps and services that continuously monitor, share, and analyze health-related data from users’ everyday life.

Samsung has revealed the most recent version, Samsung Health Research Stack 2.0 Beta, which follows the releases of Samsung Health Stack Alpha in 2022 and Samsung Health Stack 1.0 in 2023. With a focus on supporting the research ecosystem as part of the recently released Samsung Health SDK Suite, a complete collection of software development tools for healthcare solutions, the open-source project has relaunched as Samsung Health Research Stack.

Samsung Health SDK Suite

A brand-new Samsung Health Software Development Kit (SDK) Suite was unveiled by Samsung Electronics. The SDK Suite uses Samsung’s sophisticated sensor technology and extensive Samsung Health platform to better assist developers and researchers in developing cutting-edge healthcare solutions. A wider range of partners, developers, and researchers can now easily access the new comprehensive set of sensor, data, accessory, and research stack components.

App SDK

Research on digital health is made more effective by Samsung Health Research Stack. Features include an online site to help with research design and data analysis, an app SDK for simple application construction, and a back-end service to manage data acquired by the app. The most recent version has more practical features in response to researcher feedback.

The app SDK is a development tool that lowers the time and expense needed to create digital health apps. It also facilitates the creation of wristwatch apps that use wearable sensor data in addition to research mobile apps. Researchers may now develop watch apps that measure and use body composition, blood oxygen level, and EKG data from the cutting-edge Galaxy Watch sensors thanks to improved support for the Sensor SDK. Researchers can use sleep data from the Galaxy Watch or Galaxy Ring to design applications with the help of the new Data SDK integration.

Additionally, the online portal and back-end service have been made more user-friendly and performant. With additional functionality to organize studies, the back-end architecture has been strengthened to handle data from large clinical trials. The web portal facilitates all aspects of the research process, including data analysis, progress monitoring, patient recruiting, and questionnaires.

Sensor SDK

Driving Health Service Development with Advanced Sensor Technology

With the help of the Sensor SDK, developers can leverage Samsung’s robust BioActive Sensor algorithm on the Galaxy Watch, enabling them to investigate uncharted territory in the health services industry and produce cutting-edge new products. The BioActive Sensor measures skin temperature, heart rate, ECG, and BIA. The first continuous access to Red LED and IR photoplethysmogram (PPG) sensor data is significant.

This development will contribute to the improvement of blood oxygen level (SpO2)-related health services, improving sleep quality, and more. In addition to the eight indications that were already available, such as body fat mass and skeletal muscle mass, the enhanced BIA now offers two more measurements: magnitude and degree. This allows for a more accurate examination of body composition and deeper insights into general physical health.

Data SDK

As of October, developers may leverage integrated health data from a variety of devices, including smartphones, wearables like the Galaxy Watch and Galaxy Ring, and third-party devices, by utilizing the recently added Data SDK to produce creative digital health solutions. Data SDK gives users access to the Samsung Health app’s powerful algorithm-analyzed health data, such as blood pressure, food intake, activity, sleep patterns, and blood glucose levels. Developers may work more productively when creating healthcare services to Samsung Health’s streamlined insights.

Accessory SDK

The Accessory SDK lets developers connect compatible third-party health gadgets into the Samsung Health app. Blood pressure, heart rate, glucose, and cycling sensors are examples. This allows users to examine health status data in one place without activating many third-party apps, improving user experience and expanding the health management ecosystem.

Research Stack

Allowing Research Organizations to Help Healthcare

An open-source initiative called Research Stack seeks to grow the ecosystem for digital health research. By offering the online portal, backend services, mobile and wearable app SDK, and recruiting and survey assistance, in addition to progress tracking and outcomes monitoring, Research Stack establishes an adaptable and diverse research environment. The most recent version of the Research Stack offers an extensive toolkit that was created using insightful input from research institutes and their practical experience executing intricate, large-scale projects.

The Samsung Health Research Stack 2.0 Beta version will also incorporate the Health SDK Suite’s Sensor SDK and Data SDK natively. Prominent academic institutions have already included Research Stack into their research and discovery procedures, demonstrating Samsung’s proactive involvement in the healthcare sector and offering researchers more productive investigations and significant findings.

SDC24

Any business or medical facility in the digital healthcare industry creating products that make use of wearable technology and biomarkers is welcome to apply for Samsung Health Research Stack.

On October 3 in San Jose, California, Samsung Developer Conference 2024 (SDC24) will include Samsung Health Research Stack. During the event, developers can attend a Code Lab session to get a firsthand look at the newest features.

According to Yunsu Lee, Head of Samsung Research’s Data Intelligence Team, “Samsung Health Research Stack is already being used in multiple domestic and international clinical studies that utilize Galaxy Watch.” “It want to help grow the digital health ecosystem and be a valuable partner to IT and medical professionals in accomplishing research breakthroughs with its cutting-edge wearable technology.”